These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 26098816)
1. Implantable cardioverter defibrillators in diabetics: efficacy and safety in patients at risk of sudden cardiac death. Shahreyar M; Mupiddi V; Choudhuri I; Sra J; Tajik AJ; Jahangir A Expert Rev Cardiovasc Ther; 2015; 13(8):897-906. PubMed ID: 26098816 [TBL] [Abstract][Full Text] [Related]
2. Sudden cardiac death and implantable cardioverter-defibrillators. Turakhia MP Am Fam Physician; 2010 Dec; 82(11):1357-66. PubMed ID: 21121520 [TBL] [Abstract][Full Text] [Related]
3. Do implantable cardioverter defibrillators improve survival in patients with chronic kidney disease at high risk of sudden cardiac death? A meta-analysis of observational studies. Makki N; Swaminathan PD; Hanmer J; Olshansky B Europace; 2014 Jan; 16(1):55-62. PubMed ID: 24058182 [TBL] [Abstract][Full Text] [Related]
4. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability. Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517 [TBL] [Abstract][Full Text] [Related]
6. [Sudden cardiac death in diabetes mellitus]. Israel CW; Lee-Barkey YH Herz; 2016 May; 41(3):193-200. PubMed ID: 27071967 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408 [TBL] [Abstract][Full Text] [Related]
12. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death. Das M Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):181-95. PubMed ID: 19210214 [TBL] [Abstract][Full Text] [Related]
13. Real world effectiveness of primary implantable cardioverter defibrillators implanted during hospital admissions for exacerbation of heart failure or other acute co-morbidities: cohort study of older patients with heart failure. Chen CY; Stevenson LW; Stewart GC; Bhatt DL; Desai M; Seeger JD; Williams L; Jalbert JJ; Setoguchi S BMJ; 2015 Jul; 351():h3529. PubMed ID: 26174233 [TBL] [Abstract][Full Text] [Related]
14. Implanted cardioverter defibrillators for the prevention of sudden death. Dorian P; Talajic M; Tang A Can J Cardiol; 2005 May; 21 Suppl A():31A-36A. PubMed ID: 15953942 [TBL] [Abstract][Full Text] [Related]
15. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study. Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108 [TBL] [Abstract][Full Text] [Related]
16. Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Charytan DM; Patrick AR; Liu J; Setoguchi S; Herzog CA; Brookhart MA; Winkelmayer WC Am J Kidney Dis; 2011 Sep; 58(3):409-17. PubMed ID: 21664735 [TBL] [Abstract][Full Text] [Related]
17. Implantable cardioverter-defibrillators in the elderly: rationale and specific age-related considerations. Barra S; Providência R; Paiva L; Heck P; Agarwal S Europace; 2015 Feb; 17(2):174-86. PubMed ID: 25480942 [TBL] [Abstract][Full Text] [Related]
18. Implantable cardioverter defibrillators in patients with cardiac amyloidosis. Lin G; Dispenzieri A; Kyle R; Grogan M; Brady PA J Cardiovasc Electrophysiol; 2013 Jul; 24(7):793-8. PubMed ID: 23489983 [TBL] [Abstract][Full Text] [Related]